Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 8:35 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1969–1992 of 2,293 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Cardiac Ischemia Clear all

Conditions: Coronary Disease, Healthy, Hypertrophic Cardiomyopathy, Myocardial Ischemia
Interventions: Magnetic resonance imaging; Procedure
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: Not listed
Enrollment: 249 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1997 – 2003
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Angina Pectoris, Angina, Unstable, Myocardial Infarction
Interventions: Near Infrared Spectroscopy (NIRS) Imaging, intravascular ultrasound (IVUS); Device
Lead sponsor: Infraredx; Industry
Eligibility: 18 Years and older
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 5
States / cities: Boston, Massachusetts • Burlington, Massachusetts • Royal Oak, Michigan + 2 more

Conditions: Congestive Heart Failure, Ischemic Cardiomyopathy, Mitral Valve Prolapse, Mitral Regurgitation, Aortic Valve Disease, Tricuspid Regurgitation
Interventions: Not listed
Lead sponsor: Woolsthorpe Technologies, LLC; Industry
Eligibility: 18 Years to 95 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 3
States / cities: Nashville, Tennessee • Houston, Texas

Conditions: Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome
Interventions: The Cleerly CAD Staging System; Device
Lead sponsor: Cleerly, Inc.; Industry
Eligibility: 55 Years and older
Enrollment: 7,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2029
U.S. locations: 125
States / cities: Chandler, Arizona • Scottsdale, Arizona • Sun City, Arizona + 100 more

Conditions: Coronary Artery Disease, Diabetes, Metabolic Syndrome
Interventions: Eggs; Other
Lead sponsor: University of Connecticut; Other
Eligibility: 35 Years to 70 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 2
States / cities: Storrs, Connecticut

Conditions: Coronary Artery Disease
Interventions: The Multi-vessel Coronary Artery Disease Option Grid, Usual Care; Behavioral
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 4
States / cities: Portland, Maine • Lebanon, New Hampshire • Albany, New York

Conditions: Cardiomyopathy, Chest Pain, Dyspnea
Interventions: Ranexa, Placebo; Drug
Lead sponsor: Midwest Cardiovascular Research Foundation; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Davenport, Iowa

Conditions: Coronary Artery Disease
Interventions: Prasugrel, Clopidogrel; Drug
Lead sponsor: Daiichi Sankyo; Industry
Eligibility: 18 Years to 74 Years
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 4
States / cities: La Jolla, California • Jacksonville, Florida • Cincinnati, Ohio + 1 more

Conditions: Cardiac Allograft Vasculopathy, Endothelial Dysfunction, Microvascular Coronary Artery Disease
Interventions: Blood draw to measure the levels of dd-cf DNA; Diagnostic Test
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Stents, Coronary Artery Disease, Total Coronary Occlusion, Coronary Artery Restenosis, Stent Thrombosis, Vascular Disease, Myocardial Ischemia, Coronary Artery Stenosis
Interventions: XIENCE V® Everolimus Eluting Coronary Stent, TAXUS® EXPRESS2™ Paclitaxel Eluting Coronary Stent; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 1,002 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 65
States / cities: Birmingham, Alabama • Phoenix, Arizona • La Jolla, California + 56 more

Conditions: Myocardial Infarction, Cardiovascular Death, Atherothrombosis, Stroke
Interventions: Ticagrelor 90 mg, Ticagrelor 60 mg, Ticagrelor Placebo; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 50 Years to 130 Years
Enrollment: 21,379 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 250
States / cities: Alexander City, Alabama • Athens, Alabama • Birmingham, Alabama + 247 more

Conditions: Coronary Artery Disease, Acute Coronary Syndrome
Interventions: Not listed
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 69 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2013
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Coronary Artery Disease
Interventions: Educational Intervention - Text plus DVD/VHS, Educational Intervention - Text Only; Behavioral
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years to 87 Years
Enrollment: 187 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Coronary Artery Disease
Interventions: Not listed
Lead sponsor: Cleerly, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 15,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Coronary Arteriosclerosis
Interventions: MS-CT Coronary Angiography; Procedure
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Coronary Artery Disease, Obesity
Interventions: Medium-intensity Minimally-directive Counseling; Behavioral
Lead sponsor: The Camelot Foundation; Other
Eligibility: 30 Years to 59 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2000 – 2002
U.S. locations: 2
States / cities: Chicago, Illinois • Omaha, Nebraska

Conditions: Cardiovascular Diseases, Depression, Heart Diseases, Myocardial Infarction, Angina, Unstable
Interventions: Sertraline/omega-3, Sertraline/Corn Oil; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 122 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Coronary Heart Disease
Interventions: Ateronon, Placebo; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 50 Years and older
Enrollment: 213 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Angioplasty, Transluminal, Percutaneous Coronary, Coronary Arteriosclerosis, Peripheral Arteriosclerosis
Interventions: Manual Compression, Vascular Closure Device; Other · Device
Lead sponsor: Cordis US Corp.; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 488 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007
U.S. locations: 17
States / cities: Phoenix, Arizona • Sacramento, California • Stanford, California + 13 more

Conditions: Congestive Heart Failure, Non-ischemic Cardiomyopathy
Interventions: Triheptanoin oil; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Coronary Artery Disease, Myocardial Infarction, Genomic Risk Communication
Interventions: Genetic Risk Score; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 45 Years to 70 Years
Enrollment: 216 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Coronary Artery Disease
Interventions: Riociguat (BAY63-2521); Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 90 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Coronary Artery Disease, Chronic Obstructive Pulmonary Disease
Interventions: Not listed
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 89 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Ventricular Ejection Fraction, LVF, LV Dysfunction, Atrial Enlargement, Conduction Defect, Heart Failure, Valvular Heart Disease, Ischemic Heart Disease, Cardiotoxicity, Myocardial Infarction, Dilated Cardiomyopathy, HFrEF - Heart Failure With Reduced Ejection Fraction, HFpEF - Heart Failure With Preserved Ejection Fraction, Syncope, Remodeling, Cardiac
Interventions: 15-minutes of sitting during COR ECG Acquistion; Device
Lead sponsor: Peerbridge Health, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 8
States / cities: Orange, California • Pasadena, California • Detroit, Michigan + 5 more

Search by objective public record fields.

Study of Blood Flow in Heart Muscle

SPECTACL: SPECTroscopic Assessment of Coronary Lipid

Cardiac Output Pulmonary Arterial Catheter Compared to FloWave™ 1000

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

Plasma TMAO and Choline Levels in Individuals With Metabolic Syndrome - Comparison Between Eggs and Choline Supplement.

Treatment Decisions for Multi-vessel CAD

Ranolazine in Ischemic Cardiomyopathy

Prasugrel/Clopidogrel Maintenance Dose Washout Study

Determining the Association of Microvascular Disease as Assessed by PET and Graft Injury by Donor Derived Cell Free DNA

SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)

Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin

Thrombin Regulated Platelet Activation

Impact of Health Literacy on Outcomes and Effectiveness of Shared Decision Making Programs in Patients With Chronic Diseases

Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry

Comparing Angiography: Multislice CT Versus Invasive Heart Catheterization (CACTI)

Cardiovascular Outcomes Of Diet Counseling

Omega-3 Fatty Acids to Improve Depression and Reduce Cardiovascular Risk Factors

Trial of Lycopene/Ateronon for Secondary Prevention of Coronary Heart Disease

Safety and Effectiveness Study of the Ensure Medical Vascular Closure Device

Study of the Acute Effects of Triheptanoin in Heart Failure

Myocardial Infarction Genes (MI-GENES) Study

Coronary Vasomotor Response After Riociguat Exposure

Inflammatory Biomarkers Predict Pulmonary Outcomes in Coronary Artery Bypass Grafting

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor